Anaplastic lymphoma kinase (ALK) rearrangement is a predictive factor of response to ALK inhibitors in non small cell lung cancer (NSCLC). The prevalence of ALK rearrangements is well known in Whites and Asians. | Frequency of anaplastic lymphoma kinase rearrangements in Moroccan patients with non small cell lung cancer A multiinstitutional national retrospective study